Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03665051 · ClinicalTrials.gov registry record
Electrical Stimulation of Human Myocytes in Microgravity
A clinical trial of Sarcopenia, sponsored by AdventHealth Translational Research Institute.
- Active
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT03665051 is a study of Sarcopenia that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 75 participants, roughly in line with the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT03665051, a study of Sarcopenia, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the changes of muscle, in microgravity. Which will help explain the health benefits of exercise. There are tests that can be done to tell researchers more about the human body, such as a dual energy x-ray absorptiometry (DEXA) scan, which measures body composition (fat and lean body mass). The use of muscle testing and a Handgrip test can tell us about the strength and power within an individual's muscles. A VO2 max test helps us understand the aerobic fitness level of an individual and one of the most important aspects of this study are muscle cells. A muscle biopsy allows us to obtain muscle cells from the thigh, which will be sent into space by a rocket. Researchers will study these muscle cells in a low gravity environment aboard the International Space Station. Studying the muscle cells under those conditions will potentially mimic an accelerated aging process, which will help researchers better understand muscle wasting in the elderly.
Conditions Studied
Interventions
- PROCEDURE Muscle Tissue Biopsy
- OTHER Maximal Oxygen Consumption (V02max)
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03665051
The ClinicalTrials.gov registry entry for NCT03665051 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 2 interventions - of which Muscle Tissue Biopsy is the first listed.
NCT03665051 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03665051 about?
NCT03665051 is a clinical study titled "Electrical Stimulation of Human Myocytes in Microgravity". The purpose of this study is to evaluate the changes of muscle, in microgravity. Which will help explain the health benefits of exercise. There are tests that can be done to tell researchers more about the human body, such as a dual energy x-ray absorptiometry (DEXA) scan, which measures body compos...
What is the current status of trial NCT03665051?
This trial is currently active not recruiting. The enrollment target is 75 participants. The study started on 2019-01-25. Estimated completion is 2025-12.
What conditions does trial NCT03665051 study?
This clinical trial studies the following conditions: Sarcopenia.
What interventions are being tested in trial NCT03665051?
The interventions under investigation include: Muscle Tissue Biopsy (PROCEDURE), Maximal Oxygen Consumption (V02max) (OTHER).
Who is sponsoring clinical trial NCT03665051?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03665051 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
RECRUITING · NA
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Spinal Motoneuronal Activation in Older Adults
RECRUITING · NA
-
Strength Training and Resveratrol
RECRUITING · NA
-
Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment
RECRUITING · NA
-
Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.